CEL-SCI Corporation

US$1.45As of Sun 8 Nov 2026, 12:00 UTC
AMEX:CVMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (39.14%)
Div yield —
ROE (252.53%)
Biotechnology
Beta (5Y) 0.62
PE TTM —
TSR TTM (79.55%)
Mkt cap US$25.50M
ROIC (77.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.71
18.08%
(95.33%)
Hold 11|10|4|11|2
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.03
0.03
0.03
0.03
31.54%
34.86%
22.55%
15.06%
Revenue$M
1.199
1.189
1.246
1.319
4.31%
(1.90%)
5.51%
11.28%
Peers (US$25.50M)
Cap (US$)
PE
25.74M
—
25.64M
—
Capital
TTM
5Y
10Y
Leveragex
3.288
0.050
0.051
EBIT/Intx
0.121
0.358
0.333
Own earn%
(49.71)
(63.39)
(69.60)
Sh yield%
23.22
20.62
21.26
Owners
Insiders/Inst%
2.77
52.75
Short interest%
1.91
SBC / revenue%
0.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
9–21
$1 testx
—
Incr. ROIC%
6